Combined phase I/II study of imexon (AOP99.0001) for treatment of relapsed or refractory multiple myeloma - Möhler, Thomas; Feneberg, Reinhard; Ho, Anthony Dick; Golenkov, Anatoly K.; Ludwig, Heinz; Kropff, Martin; Khuageva, Nuriet K.; Hajda, Jacek; Broen, Ingo von; Goldschmidt, Hartmut (Anti-cancer drugs, 2010)
Gesehen am 27.04.2023